Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 16INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Colonic Neoplasms 50Rectal Neoplasms 49Colorectal Neoplasms 36Pancreatic Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 9Neoplasm Metastasis 8Stomach Neoplasms 7Ovarian Neoplasms 6Carcinoma, Hepatocellular 6Lymphoma, Large B-Cell, Diffuse 5Gallbladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Bile Duct Neoplasms 5Burkitt Lymphoma 4Appendiceal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Neoplasms 3Fallopian Tube Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Osteosarcoma 2Optic Nerve Glioma 2Neurotoxicity Syndromes 2Neuroectodermal Tumors, Primitive, Peripheral 2Nasopharyngeal Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2

Interventions

Cyclophosphamide 77Paclitaxel 47Trastuzumab 40Tamoxifen 39Doxorubicin 37Docetaxel 35Radiotherapy 32Fluorouracil 26Chemotherapy, Adjuvant 26Taxes 23Epirubicin 22Carboplatin 22Filgrastim 21Specimen Handling 19Methotrexate 19Magnetic Resonance Spectroscopy 19Neoadjuvant Therapy 18aldesleukin 16Peripheral Blood Stem Cell Transplantation 16Bevacizumab 13Lapatinib 12CMF regimen 12Anastrozole 12exemestane 11Goserelin 11Capecitabine 11Biopsy 11veliparib 10sargramostim 10fludarabine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Breast Neoplasms × Oxaliplatin × Clear all
NCT01233505 2014-04-02

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Terminated
16 enrolled
BreastGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡